
    
      The expected duration of the study is approximately 59 days per subject, including 2-28 days
      of screening, treatment period 1 of 7 days, treatment period 2 of 8 days, at least 7 days of
      wash-out period, and an end of study visit, which is between 14-21 days after the last dose
      of sotagliflozin.
    
  